SINGAPORE, Sept. 17, 2026 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group”, “GNS” or the “Company”), a leading AI-powered education group, today announced that it will announce half year 2026 financial results on September 28, 2026, prior to market open.

Management will also provide updates on its AI-Powered Genius School, Genius Academy and Genius Resorts plans, Genius City model and progress, Dual Treasury strategy and status of current legal cases together with its half year 2026 financial results. The financial results are prepared on an auditor review basis.

About Genius Group

Genius Group (NYSE: GNS) is a global education group delivering AI powered, education and acceleration solutions for the future of work. Genius Group serves 6 million users in over 100 countries through its Genius City model and online digital marketplace of AI training, AI tools and AI talent. It provides personalized, entrepreneurial AI pathways combining human talent with AI skills and AI solutions at the individual, enterprise and government level. To learn more, please visit geniusgroup.ai

Forward-Looking Statements 

Statements made in this press release include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by the use of words such as “may,” “will”, “plan,” “should,” “expect,” “anticipate,” “estimate,” “continue,” or comparable terminology. Such forward-looking statements are inherently subject to certain risks, trends and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate and involve factors that may cause actual results to differ materially from those projected or suggested. Readers are cautioned not to place undue reliance on these forward-looking statements and are advised to consider the factors listed above together with the additional factors under the heading “Risk Factors” in the Company’s Annual Reports on Form 20-F, as may be supplemented or amended by the Company’s Reports of a Foreign Private Issuer on Form 6-K. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise. No information in this press release should be construed as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.

Contacts

For enquiries, contact investor@geniusgroup.ai

Chief Revenue Officer Eric Appelman to present Hydrochemolytic™ Technology as a chemical recycling solution for polyolefin-rich waste plastics, with a focus on flexible and multilayer packaging, to PepsiCo global sustainability, packaging, and innovation teams

LONDON, Ontario, Sept. 17, 2026 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that it has been invited to present at the second edition of the PepsiCo Sustainability Innovation Hub, taking place September 23, 2026, at Hábitat CDMX in Mexico City.

Highlights

  • Aduro is one of 10 companies invited to participate in the second edition of the PepsiCo Sustainability Innovation Hub on September 23, 2026, at Hábitat CDMX in Mexico City.
  • The event provides direct engagement with PepsiCo teams from LATAM and the broader global organization, including sustainability, packaging, innovation, and related technical and business functions.
  • Eric Appelman, Chief Revenue Officer, will present Hydrochemolytic™ Technology (“HCT”) as a chemical recycling pathway for complex, polyolefin-rich flexible films and multilayer plastic packaging, formats that have limited compatibility with established recycling pathways.
  • Participants are asked to address a defined PepsiCo challenge and present the proposed solution, potential value, economics, scalability, and possible areas for further exploration.
  • The presentation will reference Aduro’s ongoing work with ECOCE in Mexico evaluating representative flexible and multilayer plastic feedstocks. The program is progressing through laboratory-scale HCT testing and, if results support progression, subsequent testing in the Company’s Next Generation Process (“NGP”) Pilot Plant.
  • Technology development continues at Aduro’s NGP Pilot Plant in Canada, with operating data informing the design of the planned 10,000 metric-tonne-per-year first-of-a-kind (“FOAK”) industrial plant at Chemelot in the Netherlands.

The Innovation Hub brings external innovators into direct engagement with PepsiCo teams from LATAM and the broader global organization, including sustainability, packaging, innovation, and related technical and business functions. The event gives PepsiCo teams an opportunity to learn about emerging technologies, exchange perspectives with innovators and explore approaches relevant to packaging and other sustainability challenges.

Eric Appelman, Chief Revenue Officer of Aduro, will present HCT as a chemical recycling solution for polyolefin-rich waste plastics. HCT is being developed to convert polyethylene and polypropylene into hydrocarbon intermediates that can be returned to the plastics value chain and to expand the range of mixed waste streams suitable for chemical recycling.

Within this broader application, the presentation will focus on flexible films, multilayer plastic packaging, and other complex polyolefin-rich streams. These formats are engineered by combining materials to deliver properties such as barrier protection, strength, sealability and product protection. At end of life, however, tightly bonded layers and incompatible materials can make separation and conventional mechanical recycling challenging, affecting process efficiency and recyclate quality.

Aduro will reference its ongoing work with ECOCE in Mexico as technical context for its discussion of flexible and multilayer plastic packaging. ECOCE is a packaging collection and recycling association that includes PepsiCo among its members. The Aduro-ECOCE program is evaluating representative flexible and multilayer plastic feedstocks through laboratory-scale HCT testing and, if results support progression, subsequent testing in the NGP Pilot Plant.

The Innovation Hub format asks participants to address a defined PepsiCo challenge and present the proposed solution, potential value, economics, scalability, and possible areas for further exploration. Aduro will use this framework to present how its ongoing HCT development program applies to polyolefin-rich packaging streams, including the technical considerations for processing these materials and scaling the technology toward industrial application. Any future engagement between Aduro and PepsiCo would be subject to separate evaluation, decision-making and agreement by the parties.

Aduro is advancing HCT through its NGP Pilot Plant in Canada, where operating data are informing the design and development of the planned 10,000 metric-tonne-per-year first-of-a-kind Plant at Chemelot in the Netherlands.

Participation in the Innovation Hub provides Aduro with an opportunity to bring ongoing technical work on complex packaging streams into direct discussion with a major participant in the global packaging value chain. These discussions can provide industry perspectives on technical and commercial requirements that inform the continued development and commercialization of HCT.

“The value of the Innovation Hub is the opportunity to engage directly with PepsiCo teams around a defined packaging challenge,” said Eric Appelman, Chief Revenue Officer of Aduro. “HCT is being developed to address a broad range of polyolefin-rich waste plastics, and this event allows us to discuss how that capability could apply to complex flexible and multilayer packaging with a major participant in the global packaging value chain. Our work with ECOCE provides relevant technical context from representative streams in Mexico. Bringing those perspectives together helps us better understand the technical and commercial requirements that matter to industry as we continue to advance HCT.”

“Advancing circular packaging solutions requires collaboration across the value chain and continued exploration of emerging technologies,” said Carolina Vega, Senior Manager, Circular Economy Packaging & Recycling LATAM at PepsiCo. “The Sustainability Innovation Hub provides an opportunity for PepsiCo teams to engage with innovators, exchange perspectives, and better understand potential approaches to addressing packaging sustainability challenges. We appreciate the participation of organizations that bring diverse ideas and technical expertise to these discussions.”

About Aduro Clean Technologies

Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company’s Hydrochemolytic™ technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century. For further information, visit www.adurocleantech.com.

For further information, please contact:

Abe Dyck, Head of Corporate Development / Investor Relations
ir@adurocleantech.com
+1 226 784 8889

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian securities laws and “forward-looking statements” within the meaning of applicable U.S. securities laws, including the U.S. Private Securities Litigation Reform Act of 1995.

Forward-looking information in this news release includes, but is not limited to, statements regarding Aduro’s planned participation in the PepsiCo Sustainability Innovation Hub 2026; the expected objectives and potential benefits of the event; the Company’s presentation of Hydrochemolytic™ Technology (“HCT”) and its potential application to flexible films and multilayer plastic packaging; the ongoing evaluation of flexible and multilayer plastic feedstocks through the Company’s work with ECOCE; the potential progression of representative packaging materials through the Company’s laboratory and pilot-scale development program; the potential for future discussions or other engagement with PepsiCo following separate evaluation and decision-making processes; and the Company’s broader technology development and commercialization activities.

Forward-looking information is based on management’s current expectations, estimates, projections, and assumptions, and is subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. These risks include, but are not limited to, changes to the timing or scope of the Innovation Hub; the possibility that Aduro’s participation may not result in any further engagement or commercial arrangements with PepsiCo; the results of technical evaluation of flexible and multilayer plastic feedstocks; technology development and scale-up risks; the ability to secure and maintain required commercial, feedstock, and strategic relationships; changes in market, regulatory, or economic conditions; availability of capital; and other risks described in the Company’s public disclosure filings available on SEDAR+ at www.sedarplus.ca and with the U.S. Securities and Exchange Commission at www.sec.gov.

Readers are cautioned not to place undue reliance on forward-looking information, which speaks only as of the date of this news release. Except as required by applicable law, Aduro undertakes no obligation to update or revise any forward-looking information.

Aduro PepsiCo Innovation Hub

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ed4b688e-151d-4366-b096-db56458f80d2

QuantumQ Security Advances a Novel “Detect, Encrypt and Verify” Approach

This announcement follows the appointment of former Mossad chief Yossi Cohen as the President of its Scientific Advisory Board who, among other duties, will contribute to QXL’s expansion into the defense and security markets

TEL AVIV, Israel, Sept. 17, 2026 (GLOBE NEWSWIRE) — Quantum X Labs Inc. (Nasdaq: QXL) (“Quantum X Labs” or the “Company”), a quantum technology company developing technologies across quantum computing, sensing, simulation and cybersecurity, today announced, that as part of its QuantumQ Security operation, it has launched a multi-dimensional quantum cybersecurity architecture program designed around three complementary security dimensions: Detect, Encrypt and Verify.

This announcement by Quantum X Labs follows the appointment of former Mossad chief Yossi Cohen as the President of its Scientific Advisory Board. Cohen will help shape its strategic direction across quantum computing, quantum error correction, quantum software for clinical trials, quantum cybersecurity and quantum sensing, with a particular focus on expanding the Company’s operations and commercializing its technologies for the defense, aerospace, homeland security and critical infrastructure markets.

The initiative reflects QuantumQ Security’s approach to cybersecurity in the emerging quantum era. While much of the cybersecurity industry is focused on adapting or strengthening classical security methods to address quantum-era threats, QuantumQ Security is pursuing a different technological direction: making the properties of quantum mechanics an integral part of the protection architecture itself.

The architecture currently comprises three technology programs, each at a different stage of research, development, validation and intellectual-property activity. The three dimensions are intended to form a broader security architecture:

  • DETECT– identify anomalous activity and potential attacks.
  • ENCRYPT– protect the confidentiality of information.
  • VERIFY– establish authenticity, integrity and ownership.

Quantum X Labs believes the Detect, Encrypt and Verify combination represents a broader approach to the quantum cybersecurity challenge. Rather than treating quantum computing solely as a new threat requiring modifications to existing cybersecurity infrastructure, QuantumQ Security is investigating how quantum mechanics itself can become part of the security infrastructure.

“Quantum computing is forcing the cybersecurity industry to reconsider some of its most fundamental assumptions,” said Prof. Nir Sharon, Chief Technology Officer of Quantum X Labs. “Our objective with QuantumQ Security is not simply to adapt yesterday’s security architecture to tomorrow’s computers. We are developing technologies across detection, encryption and verification that explore how quantum properties themselves can become part of the protection architecture. LayerQake, Qatacomb and our verification technologies represent three different dimensions of that strategy and, together, our vision for a more comprehensive quantum-native cybersecurity platform.”

The Company noted that the three technology programs are currently at different stages of development and intellectual property submission and protection, and that further theoretical validation, simulation, prototype development and testing may be required before individual technologies or an integrated platform can be commercialized.

Quantum X Labs intends to continue advancing each technology independently while evaluating opportunities to integrate the three dimensions into a unified QuantumQ Security architecture designed for the cybersecurity requirements of the quantum computing era

About Quantum X Labs Inc.

Quantum X Labs Inc. and its subsidiaries are focused on quantum technology, digital advertising and computing and enterprise artificial intelligence (AI) solutions. Quantum X Labs Ltd. is focused on developing and promoting quantum algorithms for the transportation, drug discovery and security segments as well as developing quantum- based GPS replacement and quantum atom accuracy solutions. Gix Media develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and routing internet user traffic to its customers. Metagramm is a developer of grammatical error correction software and offers tools for writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using artificial intelligence and machine learning technology.

For more information about Quantum X Labs, visit https://quantumxlabs.xyz/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Forward-looking statements contained in this press release include, but are not limited to, statements regarding Quantum X Labs’ and its subsidiaries’ strategic and business plans, technology, relationships, objectives and expectations for its business, growth, the impact of trends on and interest in its business, intellectual property, products and its future results, operations and financial performance and condition and may be identified by the use of words such as “may,” “seek,” “will,” “consider,” “likely,” “assume,” “estimate,” “expect,” “anticipate,” “intend,” “believe,” “do not believe,” “aim,” “predict,” “plan,” “project,” “continue,” “potential,” “guidance,” “objective,” “outlook,” “trends,” “future,” “could,” “would,” “should,” “target,” “on track” or their negatives or variations, and similar terminology and words of similar import, generally involve future or forward-looking statements. For example, the Company is using forward-looking statements when it discusses the development, validation, intellectual-property protection and potential commercialization of its Detect, Encrypt and Verify quantum cybersecurity technologies; the integration of such technologies into a unified QuantumQ Security architecture; the anticipated capabilities, advantages and potential applications of its quantum-native cybersecurity approach; the expected impact of Mr. Cohen’s appointment to the Scientific Advisory Board; the Company’s strategic direction and expansion into the defense, aerospace, homeland security and critical infrastructure markets; and the potential market opportunities for the Company’s quantum cybersecurity technologies and platform. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s most recent Annual Report on 10-K and in subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Quantum X Labs is not responsible for the content of third-party websites.

Investor Relations Contacts:

Michal Efraty
Investor Relations
michal@efraty.com 

Beam Global CEO Desmond Wheatley and Masdar City’s Mahmoud Alhosani Sign Memorandum of Understanding

Beam Global CEO and President Desmond Wheatley signs the Memorandum of Understanding with Mahmoud Alhosani, Executive Director, Masdar City.
Beam Global CEO and President Desmond Wheatley signs the Memorandum of Understanding with Mahmoud Alhosani, Executive Director, Masdar City.

Beam Middle East and Masdar City Sign Memorandum of Understanding

Representatives from Beam Middle East and Masdar City at the Memorandum of Understanding signing ceremony in Masdar City, Abu Dhabi, UAE.
Representatives from Beam Middle East and Masdar City at the Memorandum of Understanding signing ceremony in Masdar City, Abu Dhabi, UAE.

Beam Global CEO Desmond Wheatley and Masdar City’s Mahmoud Alhosani Sign Memorandum of Understanding

Beam Global CEO and President Desmond Wheatley signs the Memorandum of Understanding with Mahmoud Alhosani, Executive Director, Masdar City.
Beam Global CEO and President Desmond Wheatley signs the Memorandum of Understanding with Mahmoud Alhosani, Executive Director, Masdar City.

SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) — Beam Global (Nasdaq: BEEM) and Beam Middle East, leading providers of innovative and sustainable infrastructure solutions for energy storage and security, electrification of mobility, and smart city infrastructure, today announced that Beam Middle East and Masdar City Free Zone have signed a Memorandum of Understanding (MOU) to explore opportunities to incorporate Beam’s smart-energy and clean-mobility technologies into the Masdar City ecosystem. Following Beam Middle East’s licensing through Masdar City Free Zone, this exploratory agreement aims to advance sustainable mobility and clean‑energy innovation across the UAE. This partnership comes at a time when, according to Strategy& (part of the PWC Network) Gulf Cooperation Council (GCC) countries are targeting green investments and economic transformations in the trillion-dollar range.

“Partnering with Masdar City, a global leader in sustainable urban development, is a major milestone for Beam Global as we expand our footprint in the Middle East,” said Desmond Wheatley, CEO of Beam Global. “Our sustainable mobility, energy storage and smart city solutions are engineered to deploy rapidly without grid constraints, making them a perfect fit for Masdar City’s vision of a clean, resilient, and zero-carbon future while prioritizing sustainability in urban infrastructure and transportation.”

As part of this collaboration, Beam Middle East will introduce and supply advanced energy systems for potential application within the ecosystem, including off‑grid EV charging infrastructure, solar‑integrated e‑bike solutions, and other clean‑energy mobility technologies designed to reduce emissions and expand access to sustainable transportation. These solutions align directly with the UAE’s ambition to become a global leader in renewable energy and climate‑positive development.

These technologies fit naturally into the smart mobility ecosystem fostered by Masdar City Free Zone, particularly within the Smart and Autonomous Vehicle Industries (SAVI) cluster. Established at Masdar City to position Abu Dhabi as a leading hub for advanced transportation, the SAVI cluster provides a progressive regulatory framework and green infrastructure designed to accelerate the evaluation and commercialization of smart transit solutions. Operating within this environment, the Free Zone empowers licensed partners like Beam Middle East to explore how off-grid energy and e-mobility systems can support cleaner, more resilient urban infrastructure.     

“For nearly two decades, Masdar City has served as a global benchmark and proven enabler for sustainable urban innovation,” said Dr. Mohamed Al Breiki, Executive Director of Masdar City. “Integrating Beam Global into our Free Zone ecosystem creates a valuable opportunity to explore next-generation mobility and off-grid energy technologies. In alignment with national goals for resilient, high-performance infrastructure, we look forward to evaluating how these innovative solutions can contribute to cleaner, smarter urban environments across the UAE and beyond.”

Mahmoud Al Hosani, Executive Director of Finance and Support Services at Masdar City, added: “Attracting a Nasdaq-listed innovator like Beam Global into the Masdar City Free Zone highlights the strength of our commercial ecosystem and our commitment to providing seamless support services for international clean-tech leaders. By offering a competitive, business-friendly environment backed by robust operational support, we empower high-growth companies to establish a strong regional footprint in Abu Dhabi. We look forward to facilitating Beam Middle East’s growth as we explore sustainable energy solutions within our ecosystem.”

This agreement comes at a time of accelerated climate action across the UAE and the wider region, with countries advancing their commitments under the Paris Agreement and working towards long-term net-zero targets. The UAE’s Net Zero by 2050 Strategy provides a framework for decarbonization across key sectors including power, industry, transport and buildings, creating further opportunities for innovative private-sector solutions. Together, Beam Middle East and Masdar City Free Zone reaffirm their dedication to supporting the UAE’s sustainability agenda and exploring new opportunities fora cleaner, smarter, and more energy‑efficient future for generations to come.

About Beam Global
Beam Global is a sustainable technology innovator that develops and manufactures infrastructure products and technologies. The Company operates at the nexus of innovative and reliable energy, transportation and smart city solutions with a focus on sustainable energy infrastructure, rapidly deployed and scalable EV charging solutions, safe energy storage, energy security and intelligent infrastructure. With operations in the U.S., Europe and the Middle East, Beam Global develops, patents, designs, engineers and manufactures unique and advanced technology solutions that power transportation, provide secure sources of electricity, enable smart city services, save time and money, and protect the environment. Beam Global is headquartered in San Diego, CA, with facilities in Yuma, AZ; Broadview, IL; Belgrade and Kraljevo, Serbia; and Abu Dhabi, UAE. Beam Global is listed on Nasdaq under the symbol BEEM. For more information visit BeamForAll.com, LinkedIn, YouTube, Instagram and X.

About Masdar City
Masdar City is a pioneering sustainable urban community, a world-class business and technology hub, and a “green print” for cities that want to be part of the solution to climate change. With one of the largest clusters of LEED Platinum buildings in the world, we are dedicated to creating a new kind of city, a new way of working and living, and a more sustainable future for everyone. The Masdar City Free Zone is a diverse, innovative, and ambitious group of over 2,000 organizations that benefit from comprehensive business support as well as the city’s rich ecosystem. Tenants include the International Renewable Energy Agency (IRENA), the UAE Space Agency, Siemens Energy, G42, the Advanced Technology Research Council, several Fortune 500 companies, and the Mohamed bin Zayed University of Artificial Intelligence. The Masdar City Free Zone also includes The Catalyst, a clean-tech start-up investor powered by both Masdar City and BP.

Forward-Looking Statements
This Beam Global Press Release may contain forward-looking statements. All statements in this Press Release other than statements of historical facts are forward-looking statements. Forward-looking statements are generally accompanied by terms or phrases such as “estimate,” “project,” “predict,” “believe,” “expect,” “anticipate,” “target,” “plan,” “intend,” “seek,” “goal,” “will,” “should,” “may,” or other words and similar expressions that convey the uncertainty of future events or results. These statements relate to future events or future results of operations. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause Beam Global’s actual results to be materially different from these forward-looking statements. Except to the extent required by law, Beam Global expressly disclaims any obligation to update any forward-looking statements.

Investor Relations
Luke Higgins
+1 858-261-7646
IR@BeamForAll.com

Media Contact
Lisa Potok
+1 858-327-9123
Press@BeamForAll.com

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/468ab61b-fd5d-406f-920b-ba412876b855

https://www.globenewswire.com/NewsRoom/AttachmentNg/3ba5e43f-5d52-4047-911a-c44f97e30560

https://www.globenewswire.com/NewsRoom/AttachmentNg/ae1aef87-7737-4a47-adc5-64782772431a

Summary:

  • Profit before value adjustments and tax came to DKK 146 million for the period, down by DKK 192 million on the same period last year.
  • Net interest income came to DKK 250 million for the first half of 2026, which is DKK 118 million lower than for the same period last year.
  • Comprehensive income was DKK 262 million for the period compared to DKK -139 million for the same period last year.
  • Net lending amounted to DKK 6.4 billion for the first half of 2026 versus DKK 1.3 billion for the same period last year. The value of total loans and leases was up by DKK 7.5 billion to DKK 207.2 billion during the first half of 2026.
  • Common Equity Tier 1 (CET1) capital, which corresponds to equity, rose from DKK 10,099 million at end-2025 to DKK 10,361 million.

Since 1899, KommuneKredit has provided funding to municipalities and regions in Denmark by issuing bonds in the capital markets. That funding model was changed on 26 March 2025 and implemented in the Act on KommuneKredit (KommuneKredit-loven) with effect from 15 September 2026. The Danish State buys KommuneKredit’s bonds at interest rates corresponding to the State’s own funding costs. The new funding model has resulted in lower lending rates and lease payments since 1 April 2025 and, when fully phased in, the model is expected to create annual savings of up to DKK 1 billion for the Danish society, savings that will ultimately benefit Danish citizens and taxpayers.

Interim results impacted by lower interest rate margin
Profit before value adjustments and tax came to DKK 146 million for the first half of 2026 compared to DKK 338 million for the same period last year. The decline mainly reflects lower net interest income and a positive effect on profit of the sale of KommuneKredit’s properties at Kultorvet, Copenhagen, in the first half of 2025. The lower interest rate margin has resulted in a reduction of net interest income, which came to DKK 250 million for the first half of 2026 compared to DKK 368 million for the same period last year. At the same time, the recent interest rate margin decline in May has contributed to positive value adjustments of financial instruments of DKK 190 million for the period. As a result, comprehensive income came to DKK 262 million for the period and is transferred to equity in its entirety, resulting in equity of DKK 10,361 million. At 30 June 2026, the equity ratio was 4.2 per cent, which is above the Board of Directors’ target of an equity ratio of at least 3 per cent.

High lending activity in the first half of 2026
Net lending, i.e. new loans and leases less repayments and redemptions, amounted to DKK 6.4 billion for the first half of 2026 versus DKK 1.3 billion for the same period last year. Net lending was DKK 0.9 billion ahead of expectations, and at 30 June 2026, the value of total loans and leases was DKK 207.2 billion.

Outlook
With net interest income of DKK 250 million for the first half of 2026, we maintain our expectation of net interest income of DKK 500 million for the full year 2026. As a result of the higher-than-expected net lending in the first half of 2026, we have upgraded our expectation for net lending for the full year 2026 from DKK 5.5 billion to DKK 6.5 billion. The upward adjustment allows for known repayments and expected lower lending activity in the second half of 2026 following the high activity level in the first half of the year. Our expectation for administrative expenses is unchanged at DKK 225 million. Accordingly, we still expect profit for the year before value adjustments and tax to total DKK 275 million.

Contact person:
Jens Lundager, Chief Executive Officer | Phone +45 3369 7622 | E-mail: jlu@kommunekredit.dk

Attachments

KING CITY, Ontario, Sept. 17, 2026 (GLOBE NEWSWIRE) — TWC Enterprises Limited (“TWC”) today announced that the Toronto Stock Exchange (the “TSX”) has accepted a notice filed by TWC of its intention to make a normal course issuer bid through the facilities of the TSX or alternative Canadian trading systems.

The notice provides that TWC may, during the twelve-month period commencing September 20, 2026 and ending September 19, 2027 purchase up to 1,205,556 common shares (“Common Shares”) in total, being approximately 5% of the issued and outstanding Common Shares. The price that TWC will pay for any such Common Shares will be the market price at the time of acquisition. Management of TWC will determine the actual number of Common Shares that may be purchased and the timing of any such purchases.

Under the current normal course issuer bid due to expire September 19, 2026, TWC sought to purchase up to 1,208,438 common shares through the facilities of the TSX or alternative Canadian trading systems. TWC purchased 70,500 Common Shares for cancellation under this bid at an average cost per share of $25.69. As of September 10, 2026, there were 24,111,121 Common Shares outstanding. TWC average daily trading volume for the prior six months is 1,359. Daily purchases will be limited to 1,000 common shares, other than block purchase exceptions.

TWC believes that its Common Shares have been trading in price ranges which do not adequately reflect their value in relation to the business of TWC and its future business prospects. As a result, depending upon future price movements and other factors, TWC believes that its outstanding Common Shares may represent an attractive investment. Furthermore, the purchases are expected to benefit all persons who continue to hold Common Shares by increasing their proportionate interest in TWC. All Common Shares purchased by TWC under the normal course issuer bid will be cancelled.

Corporate Profile

TWC is engaged in golf club operations under the trademark, “ClubLink One Membership More Golf.” TWC is Canada’s largest owner, operator and manager of golf clubs with 46 18-hole equivalent championship and 2.5 18-hole equivalent academy courses (including three managed properties) at 34 locations in Ontario, Quebec and Florida.

For further information please contact:

Andrew Tamlin
Chief Financial Officer
15675 Dufferin Street
King City, Ontario L7B 1K5
Tel: 905-841-5372 Fax: 905-841-8488
atamlin@clublink.ca

– This integration of Firefly’s FDA 510(k)-cleared, AI-powered EEG/ERP technology follows Radial’s August 2026 acquisition of the management services organization supporting Mindful Health Solutions, forming the country’s largest brain medicine clinical network –

KENMORE, N.Y. and NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) — Firefly Neuroscience, Inc. (“Firefly”) (NASDAQ: AIFF) today announced a strategic collaboration with Radial, operator of the country’s largest network of brain medicine clinics, to pursue the integration of Firefly’s FDA 510(k)-cleared, AI-powered Evoke™ EEG/ERP platform with RadialOS, Radial’s proprietary AI-native operating system for brain medicine.

The planned integration will incorporate objective measures of brain function into Radial’s diagnostic process, helping clinicians develop a more complete understanding of each patient, identify potentially appropriate treatment pathways, coordinate care and track outcomes over time. This integration aims to create a more informed and personalized approach to delivering brain-medicine treatments.

Radial develops the clinical infrastructure, reimbursement capabilities and AI-guided decision-support tools needed to expand access to advanced brain-medicine treatments. Its platform supports the delivery of therapies that include transcranial magnetic stimulation (“TMS”), medications and other interventional approaches, offered across its network of 27 clinics in seven states.

Firefly’s Evoke™ platform combines quantitative electroencephalography (“qEEG”) and event-related potential (“ERP”) testing with AI-powered analytics to provide clinicians with objective information about brain function. The platform is designed to help clinicians identify relevant brain-activity patterns, assess patients whose symptoms may overlap and monitor changes over time.

“Integrating Evoke™ with RadialOS represents a compelling opportunity to place objective, data-driven insights directly into the clinical workflow,” said Greg Lipschitz, Chief Executive Officer of Firefly. “Radial is building the infrastructure required to deliver advanced brain medicine at scale. We believe the combination of its operating platform and clinical reach with Firefly’s AI-powered brain-function technology could help clinicians make more informed decisions, personalize care and objectively measure how patients respond over time.”

The collaboration follows Radial’s August 2026 acquisition of the management services organization supporting Mindful Health Solutions, significantly expanding Radial’s clinical footprint and ability to deploy new brain-medicine technologies across a large patient population.

“Brain medicine treatments are advancing rapidly. It’s also true that most clinics are operating on outdated infrastructure,” said Owen Muir, M.D., co-founder and Chief Scientific Officer of Radial. “Clinicians need better tools to translate emerging evidence into personalized, real-world care. We believe integrating Firefly’s objective brain-function data into RadialOS can help close that gap—giving clinicians actionable information at the point of care and helping more patients reach the right treatment sooner.”

About Radial

Radial supports the country’s leading clinical network for brain medicine, expanding access to the world’s most advanced mental health treatments. Backed by General Catalyst, its clinical partners now include 27 clinics and more than 100 clinicians treating hundreds of thousands of patients each year, with a focus on high-acuity mental health conditions. This clinical network accepts most major insurance plans, including Medicare, Tricare, VA-CCN, Aetna, Cigna, United, and many Blues plans. By collaborating with its clinical partners to develop and implement clinical infrastructure, reimbursement tools, and RadialOS, its proprietary AI-guided decision support designed around novel psychiatry treatments like neuromodulation (e.g., TMS), medication (e.g., Spravato), and other interventional therapies, Radial is at the forefront of helping providers deliver the highest quality, most patient-centered and most innovative care, ensuring transformative brain medicine is accessible to all. Learn more at www.meetradial.com.

About Firefly Neuroscience

Firefly Neuroscience, Inc. (NASDAQ: AIFF) is an Artificial Intelligence (“AI”) company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient’s brain is functioning. Firefly’s proprietary database consists of over 200,000 EEG/ERP brain scans, which the Company believes to be the world’s largest known standardized EEG/ERP repository. Firefly’s EEG-based, AI-driven, and FDA-510(k)-cleared Evoke System is designed to support diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, ADHD, and PTSD.

Please visit www.fireflyneuro.com for more information.

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” for purposes of the federal securities laws concerning Firefly, including statements regarding the anticipated benefits, scope, and results of the collaboration between Firefly and Radial, statements regarding Radial’s business, clinic network, and expansion plans, and statements relating to Firefly’s management team’s expectations, hopes, beliefs, intentions, or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are based on current expectations and beliefs concerning future developments and their potential effects. There can be no assurance that future developments affecting Firefly will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond Firefly’s control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors” in the reports and other filings of Firefly with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of Firefly’s assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. It is not possible to predict or identify all such risks. Forward-looking statements included in this press release only speak as of the date they are made, and Firefly does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Investor & Media Contacts

For Firefly
Stephen Kilmer
(646) 274-3580
stephen.kilmer@fireflyneuro.com

For Radial
Kayli Watson
120/80 MKTG
radial@12080group.com

Vancouver, British Columbia, Sept. 17, 2026 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce additional oxide-gold assays from the 2026 drill program at its Limousine Butte Project (the “Project”, “Limo Butte”) in Nevada. These results have significantly expanded oxide gold mineralization both inside and outside of the 2026 Mineral Resource Estimate (“MRE”) pit-shell released on July 15, 2026 (see News Release). The focus of the 2026 20,000 meter drill program is resource expansion and conversion of the MRE.

NevGold CEO, Brandon Bonifacio, comments: “It is extremely encouraging to have thick intercepts of high-grade oxide gold grades over 1.00 g/t Au that have expanded mineralization inside and outside of the 2026 MRE pitshell. The initial 2026 drillholes at the Bullet Zone have delivered on expanding both oxide gold and antimony mineralization, and the grades intercepted have been higher than the average MRE grade profile. Our geological interpretation is that gold and antimony were deposited in the same general area during two separate mineralizing events, which explains why certain parts of the deposit are higher-grade oxide gold and others are higher-grade oxide antimony. This is important to highlight as it creates future operational and development flexibility as Limo is advanced. With two drill rigs and approximately 9,000 meters of drilling completed to date, and 33 drillholes with assays pending, our Technical Team continues to test the resource expansion potential with each drillhole. We are fully funded for the next 12-18 months with over $45 million in treasury, and our team is focused on delivering on one of the most important gold-antimony projects in the United States.” 

Key Highlights

  • High-grade oxide gold mineralization significantly expanded outside 2026 MRE pit-shell with 1.06 g/t oxide Au over 42.7 meters:
    • LB26-007 Lower (expansion outside of 2026 pit-shell): 1.89 g/t oxide Au over 18.3 meters within 1.06 g/t oxide Au over 42.7 meters (terminated in 0.52 g/t oxide Au)
    • LB26-007 Upper (infill): 0.20% Sb over 16.8 meters
  • High-grade oxide gold mineralization significantly expanded inside 2026 MRE pit-shell with 5.00 g/t oxide Au over 3.0 meters
    • LB26-004 (expansion inside of 2026 pit-shell): 5.00 g/t oxide Au over 3.0 meters within 1.23 g/t oxide Au over 27.4 meters
    • Drillhole LB26-004 converted unmineralized blocks within the 2026 MRE pit-shell, immediate mineralization expansion (Figure 1, Figure 2)
  • Company remains fully funded for the next 12-18 months with +$45 million in treasury
  • 40 holes completed, 33 holes with assays pending after this News Release
  • Advancing Preliminary Economic Assessment (“PEA”) and Engineering Studies at Limo Butte 

Limo Butte Planned 2026-2027 Activities / Status Update
NevGold will continue its active exploration program at Limo Butte including:

  • Continuing to drill test gold-antimony targets (~20,000 meters is planned in 2026 focused on the Bullet Zone / Armory Fault discoveries and resource conversion);
  • Advancing metallurgical testwork (ongoing);
  • Complete initial gold-antimony Mineral Resource Estimate (MRE) (completed, July 15);
  • Advancing PEA / Engineering Studies (in process).

Figure 1 – Resurrection Ridge resource area with completed 2026 drilling. Figure includes outline of 2026 AuEq. resource pitshell, priority expansion area for ongoing 2026 drilling, and intercepts for completed 2026 drilling. Ongoing road and pad construction efforts are also shown, highlighting focused efforts to expand Au and Sb mineralization to the east under the dolomite thrust. To view image please click here

Figure 2 – Cross section with Au values from 2026 MRE block model and Au intercepts from all drilling along section. The drillholes in the 2026 drill program have expanded oxide mineralization both inside and outside of the recently announced 2026 MRE pit-shell. To view image please click here

2026 Drilling Results – Resurrection Ridge

Hole ID Length, m* g/t Au*** % Sb*** g/t AuEq** From, m To, m
LB26-004 27.4 1.23 – 1.23 164.6 192.0
   Including 3.0 5.00 – 5.00 178.3 181.4
LB26-005 36.6 0.13 – 0.13 83.8 120.4
   Including 10.7 0.20 0.09% 0.57 109.7 120.4
LB26-006 30.5 0.18 0.08% 0.47 68.6 99.1
   Including 6.1 0.51 0.14% 1.06 74.7 80.8
LB26-007 Upper 16.8 – 0.20% 0.79 29.0 45.7
LB26-007 Lower 42.7 1.06 – 1.06 242.3 285.0
   Including 18.3 1.89 – 1.89 263.7 281.9

*Downhole thickness reported; true width varies depending on drill hole dip and is approximately 70% to 90% of downhole thickness.
**The gold equivalents (“AuEq”) are based on assumed metals prices of US$3,000/oz of gold and US$40,000 per tonne of antimony, and assumed metals recoveries of 80% for gold and 75% for antimony.
***Values less than 0.05 g/t Au and 0.05% Sb not included.

Drillhole Orientation Details

Hole ID Target Zone Easting Northing Elevation (m) Length (m) Azimuth Dip
LB26-004 RR 667217 4417168 2241 202.7 90 -80
LB26-005 RR 667217 4417167 2241 278.9 0 -90
LB26-006 RR 667217 4417168 2241 288.0 35 -70
LB26-007 RR 667173 4417250 2189 285.0 120 -60

Figure 3 – Limousine Butte Land Holdings and District Exploration Activity To view image please click here

ON BEHALF OF THE BOARD

“Signed”
Brandon Bonifacio, President & CEO

For further information, please contact Brandon Bonifacio at bbonifacio@nev-gold.com, call 604-337-4997, or visit our website at www.nev-gold.com.

Sampling Methodology, Quality Control and Quality Assurance
NevGold QA/QC protocols are followed on the Project and include insertion of duplicate, blank and standard samples in all drill holes. A 30g gold fire assay and multi-elemental analysis ICP-OES method was completed by ISO 17025 certified American Assay Labs, Reno.

Technical information contained in this news release has been reviewed and approved by Greg French, CPG, the Company’s Vice President, Exploration, who is NevGold’s Qualified Person (“QP”) under National Instrument 43-101 and responsible for technical matters of this release.

About the Company
NevGold is dedicated to discovering, de-risking, and rapidly advancing gold and critical metals projects across premier jurisdictions in Nevada and Idaho to drive shareholder value and strengthen US mineral security. The Company holds a 100% interest in the Limousine Butte (gold-antimony) and Cedar Wash (gold) projects in Nevada, and the Nutmeg Mountain (gold) and Zeus (copper) projects in Idaho. For more information, please visit www.nev-gold.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements

This news release contains forward-looking statements that are based on the Company’s current expectations and estimates. Forward-looking statements are frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “suggest”, “indicate” and other similar words or statements that certain events or conditions “may” or “will” occur. Forward-looking statements include, but are not limited to, the proposed work programs at Limousine Butte, the exploration potential at Limousine Butte, the expansion of the  recently announced MRE at Limo Butte, and future potential project milestones such as the potential Preliminary Economic Assessment (“PEA”). Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such risks include, but are not limited to, general economic, market and business conditions, and the ability to obtain all necessary regulatory approvals. There is some risk that the forward-looking statements will not prove to be accurate, that the management’s assumptions may not be correct or that actual results may differ materially from such forward-looking statements. Accordingly, readers should not place undue reliance on the forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

Mary-Elizabeth Gifford, Chief of Global Impact at Clearmind Medicine, spoke on patient access and shared insights from Clearmind’s clinical trial at Yale and Johns Hopkins

Vancouver, Canada, Sept. 17, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (the “Company” or “Clearmind”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment  of neuropsychiatric, metabolic, and addiction disorders including Alcohol Use Disorder (“AUD”), today announced that, following an invitation from the U.S. Food and Drug Administration (“FDA”), it testified at the FDA’s history-making psychedelic hearing in the nation’s capital on September 14, 2026. Clearmind’s Chief of Global Impact, Mary-Elizabeth Gifford, briefed a federal panel convened by the FDA to evaluate “Considerations for Potential Future Therapeutic Use of Psychedelic Drugs.”

The history-making hearing marked a dedicated federal forum convened by the FDA to gather public input on the potential future therapeutic use of psychedelic drugs, bringing together senior FDA officials and federal partners from Substance Abuse and Mental Health Services Administration (SAMHSA), the National Institutes of Health and the Veterans Health Administration.

Invited to address the question of “Patient Access” Gifford said: “At Clearmind Medicine, our clinical trial at Yale and Johns Hopkins have generated findings suggesting that a next-generation category of psychedelics, neuroplastogenic compounds, which retain the therapeutic benefits of neuroplasticity enhancement while eliminating the hallucinogenic effects of legacy psychedelics, may help mitigate the need for expensive supervised dosing. Our findings have led us to believe that this may represent a scalable treatment model that is a replicable and shareable opportunity for the future of American health.”

In addition to soliciting expertise on patient access, the FDA’s hearing also invited testimony on provider training and credentialing, patient safety, and best practices for data collection and standardization.

Tiffany R. Farchione, M.D., Director, Division of Psychiatry, Center for Drug Evaluation and Research (CDER) Office of New Drugs, sat on the day’s Federal Listening Panel, as did senior leadership from the Substance Abuse and Mental Health Services Administration (SAMHSA), the National Institute on Drug Abuse (NIDA), the Advanced Research Projects Agency for Health (ARPA-H) and the Veterans Health Administration. Approximately 1,800 participants attended the hearing in person and virtually.

At the hearing, Gifford told the FDA panel that next-generation psychedelic neuroplastogens that do not need expensive supervised dosing may reduce health disparities and achieve patient access for those with intractable substance use disorders and “myriad other diagnoses that could be treated safely under medical care.” 

She concluded: “This secures responsible patient access, not through new expensive frameworks that are yet to be built, but through America’s already existing primary care and VA resources.”

MEAI, Clearmind’s proprietary drug candidate for the treatment of AUD, a condition that affects one in ten Americans, and is considered a leading cause of preventable deaths for working age adults, is currently being evaluated in FDA-approved clinical trial at Yale University Medical School and Johns Hopkins University. MEAI is also among a limited number of non-hallucinogenic, psychedelic-derived neuroplastogen candidates to have advanced to a Phase 2a clinical trial.

“We are grateful to the FDA and federal health officials for leading this important national conversation and for its visionary encouragement of responsible biopharma innovation in addiction treatment, including the treatment of AUD,” said Adi Zuloff-Shani, Ph.D., Chief Executive Officer of Clearmind Medicine. Zuloff-Shani, Ph.D. added, “We appreciate the opportunity to contribute to this emerging technological field, with MEAI representing our commitment to developing innovative treatments that could ultimately be both effective and more accessible to patients. Mary-Elizabeth Gifford speaks for all of us at Clearmind, articulating our collective mission to bridge rigorous evidence-based research with federal policy that could potentially help us to accelerate improved care for patients across the US and globally.”

Gifford, Clearmind’s Chief of Global Impact, anchors the biopharma’s presence in New York City and Washington, D.C., and has been described by Spirituality & Health magazine as “the most quietly influential woman working in psychedelics today.” Her pro-bono contributions to the field of psychedelic medicine include chairing the steering committee for the Psychedelic Medicine Coalition Annual Federal Psychedelic Summit at the National Press Club and heading the non-profit Global Wellness Institute’s Psychedelics & Healing Initiative.

About Clearmind Medicine Inc.

Clearmind is a clinical-stage neuroplastogens pharmaceutical biotech company focused on the discovery and development of non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements.

The Company’s intellectual portfolio currently consists of nineteen patent families, including 32 granted patents. The Company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Shares of Clearmind are listed for trading on Nasdaq under the symbol “CMND.”

For further information, visit: https://www.clearmindmedicine.com or contact:

Investor Relations
invest@clearmindmedicine.com
www.Clearmindmedicine.com

Forward-Looking Statements:

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the potential therapeutic profile of neuroplastogenic compounds, the development and clinical advancement of MEAI, the potential benefits of the Company’s product candidates, the implications of its participation in the FDA hearing, and the Company’s plans, objectives and expectations regarding future research, development and commercialization activities. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s annual report on Form 20-F for the fiscal year ended October 31, 2025 and subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Clearmind is not responsible for the contents of third-party websites.

YardFlow brings Rail Vision’s perception technology to a broad range of rail operations and will support the Company’s expanding commercial collaboration with Railserve, a Marmon Rail company.

Ra’anana, Israel, Sept. 17, 2026 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN, FSE:C80) (“Rail Vision” or the “Company”), an early commercialization stage technology company transforming railway safety through advanced AI-integrated sensing systems, today announced the launch of YardFlow™, its leading solution for industrial and freight railyards, designed to address a broad range of operational requirements across diverse yard environments.

The existing YardFlow Flex™ (formerly ShuntingYard) remains available as a specialized multi-spectral option for special railyard applications and use cases in the industry, requiring enhanced performance in harsh weather and low-visibility conditions, providing customers with a choice tailored to their specific operational needs.

The Company believes that YardFlow will also support Rail Vision’s expanding commercial collaboration with Railserve, a Marmon Rail company. As previously announced, in 2024, Rail Vision and Railserve entered into a commercialization agreement for the deployment of the Company’s AI-based railyard systems and, in May 2026, signed a non-binding MOU to explore additional deployments, railcar mover applications, broader railyard solutions and other commercial opportunities. YardFlow is designed, among other applications, to address these types of applications as Rail Vision and Railserve continue to explore opportunities to expand their collaboration.

“YardFlow was developed based on years of extensive experience and valuable customer feedback, mainly based on our ongoing collaboration with Railserve. We believe that these insights are helping us to set a new standard for the market,” said David BenDavid, Chief Executive Officer of Rail Vision. “We have optimized our platform to provide a high-performance and cost-effective solution tailored to the evolving needs of dynamic yard environments, enabling us to bring our technology to a much broader customer base.”

Powered by high-sensitivity electro-optical vision sensors and proprietary deep-learning algorithms, YardFlow detects on-track or near-track hazards at distances of up to 200 meters (650 ft) and provides real-time alerts to help operators prevent incidents and maintain continuous switching operations. Its compact, modular structure enables simple installation across switching locomotives and railcar movers in freight and industrial rail operations, while built-in video recording and analytics provide actionable operational insights.

For more information about YardFlow, visit railvision.io/yardflow/

About Rail Vision Ltd.

Rail Vision (Nasdaq: RVSN, FSE: C80) is an early commercialization stage technology company transforming railway safety through advanced AI-integrated sensing systems. The Company develops and commercializes proprietary, electro-optic platforms that provide extended-range situational awareness and real-time hazard detection. Using machine learning algorithms to identify and classify obstacles, Rail Vision’s technology enhances safety, improves operational efficiency, and supports continuity across deployments.

The Company’s cloud-based platform complements its products by transforming railway operational data into actionable insights that help optimize performance, reduce downtime, and improve safety. As the Company expands its global footprint, it delivers AI-driven perception that supports safer operations, reduces operational risk, and enables the transition to fully autonomous operations.

Rail Vision holds a 51% stake in Quantum Transportation, which has an exclusive sub-license for rail technologies under an innovative pending patent in quantum error correction owned by Ramot, the technology transfer company of Tel Aviv University.

For more information, please visit https://www.railvision.io/

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the expected commercialization, deployment, capabilities, performance and benefits of YardFlow; the potential expansion of the Company’s collaboration with Railserve and related commercial opportunities; the ability of YardFlow to serve a broad range of railyard applications; and the Company’s future business plans, objectives and growth opportunities. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the SEC on March 31, 2026. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Rail Vision is not responsible for the contents of third-party websites.

Investor Relations:
Michal Efraty
investors@railvision.io

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.